Abstract submission has been extended.

Submission Deadline: 28 May 2019

Abstract-based presentations will be given during sessions held Sunday–Wednesday, 8–11 September 2019. See the Preliminary Program.

Professionals and trainees involved with prenatal diagnosis and therapy are invited to submit an abstract. Abstracts are encouraged for the categories listed at the bottom of this page. You do not need to be an ISPD member to submit an abstract or present, although members receive discounted registration rates.

PLEASE NOTE: ISPD will not accept late-breaking abstracts this year. All abstracts must be submitted during the regular submission period.

Abstract Types

Oral Presentation

  • Podium presentation in a concurrent session
  • Wide-screen slide format (16:9)
  • Peer reviewers will select the top oral abstracts for presentation in a top abstracts plenary session.
  • Peer reviewers will select abstracts for presentation in a current hottest topics plenary session.
  • Abstracts by early career investigators will be considered for the Joe Leigh Simpson Award.

Poster Presentation

  • Attended poster session on either Monday, 9 September 2019, or Tuesday, 10 September 2019
  • Poster authors with the highest peer review scores will be invited to give a brief oral presentation during a "lightning communication" session on either Monday, 9 September 2019 or Tuesday, 10 September 2019. Each presenter will have 2 minutes to speak and 2 minutes for Q&A. These authors are also expected to present the paper poster during an attended poster session.

All presenters must register for the conference, at least for the day of their assigned session. Presenters who are unable to attend on their assigned day may have a co-author present in their place and must contact ISPD Headquarters to make this substitution.

Abstract Categories

The following categories will be available for submission. This list may be updated before abstract submission opens.

  • Cytogenetics and Molecular Genetics
  • Epigenetics and development
  • Fetal and placental development and pathology
  • Fetal imaging: Ultrasound and Magnetic Resonance Imaging
  • Fetal medical and surgical therapy
  • Global issues in prenatal diagnosis and screening
  • Maternal serum/NT screening for aneuploidy
  • Noninvasive prenatal diagnosis and screening
  • Pre-implantation genetic diagnosis and screening
  • Prenatal diagnosis of single gene disorders / inborn errors of metabolism
  • Prenatal diagnostic procedures
  • Prenatal genetic counseling
  • Prenatal prediction of adverse pregnancy outcomes (e.g pre-eclampisa / preterm labour / growth restriction and stillbirth)
  • Psychosocial, legal and ethical issues in prenatal screening and diagnosis
  • Reproductive genomics, metabolomics and proteomics
  • Screening for single gene disorders
  • Teratogens and Fetal infection
  • Twins
  • Other
Published abstracts from previous years are available through the Downloads page.